| 2AMD | B:-1-14,B:100-197; A:15-99; B:15-99; A:-3-14,A:100-197 | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9 |
| 2AMQ | B:1-14,B:100-197; A:3-14,A:100-197; A:15-99; B:15-99 | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3 |
| 2D2D | B:1-14,B:100-197; A:3-14,A:100-197; A:15-99; B:15-99 | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2 |
| 2GT7 | A:1-14,A:100-197; B:15-99; A:15-99; B:1-14,B:100-197 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE AT PH 6.0 IN THE SPACE GROUP P21 |
| 2GT8 | A:3-14,A:100-197; A:15-99 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) IN THE SPACE GROUP P43212 |
| 2GTB | A:2-14,A:100-197; A:15-99 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP P43212 |
| 2GX4 | A:1-14,A:100-197; A:15-99 | CRYSTAL STRUCTURE OF SARS CORONAVIRUS 3CL PROTEASE INHIBITOR COMPLEX |
| 2H2Z | A:1-14,A:100-197; A:15-99 | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI |
| 2HOB | A:1-14,A:100-197; A:15-99 | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI IN COMPLEX WITH A MICHAEL ACCEPTOR N3 |
)
)